Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2

This publication has 78 references indexed in Scilit:

• A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines
  FEBS Letters, 1996
• Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors
  Journal of Molecular Endocrinology, 1996
• Ras-Dependent Activation of Fibroblast Mitogen-Activated Protein Kinase by 5-HT_1A Receptor via a G Protein βγ-Subunit-Initiated Pathway
  Biochemistry, 1996
• Classification and nomenclature of somatostatin receptors
  Trends in Pharmacological Sciences, 1995
• On the Mechanism of Cytosolic Phospholipase A2 Activation in CHO Cells Carrying Somatostatin Receptor: Wortmannin-Sensitive Pathway to Activate Mitogen-Activated Protein Kinase
  Biochemical and Biophysical Research Communications, 1994
• Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain
  FEBS Letters, 1993
• The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
  Cell, 1993
• Molecular biology of somatostatin receptors
  Trends in Neurosciences, 1993
• Somatostatin analogue rc‐160 inhibits the growth of transplanted colon cancer in rats
  International Journal of Cancer, 1991
• Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa‐2 cell line
  FEBS Letters, 1985